" /> Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy - CISMeF





Preferred Label : Optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy;

CISMeF acronym : DOA ;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Dominant optic atrophy plus syndrome; DOA ;

Description : Syndromic optic atrophy, also known as DOA syndrome, is a neurologic disorder characterized most commonly by an insidious onset of visual loss and sensorineural hearing loss in childhood with variable presentation of other clinical manifestations including progressive external ophthalmoplegia (PEO), muscle cramps, hyperreflexia, and ataxia. There appears to be a wide range of intermediate phenotypes (Yu-Wai-Man et al., 2010).;

Inheritance : Autosomal dominant;

Molecular basis : Caused by mutation in the OPA1 mitochondrial dynamin-like GTPase gene (OPA1, 605290.0011);

Prefixed ID : #125250;

Détails


Vous pouvez consulter :


Nous contacter.
31/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.